Duloxetine capsules recalled over N-nitroso-duloxetine above the FDA recommended limit
Breckenridge Pharmaceutical is recalling 3,397 bottles of Duloxetine Delayed-Release Capsules, 60 mg, over the presence of N-nitroso-duloxetine above the FDA recommended limit.
- Product
- Urinary Tract Infection Test
- Category
- Drug
- Distribution
- Distributed nationwide